The side effect no one mentions: you move less on a GLP-1, and you don't notice

The 30-second summary

• New research presented at ENDO 2026 found that people losing weight on GLP-1 drugs became measurably less active: average steps fell from about 5,000 to 4,500 a day, and moderate-to-vigorous activity dropped from 28 to 22 minutes.
• This matters because moving less is exactly how the body loses muscle instead of fat, and the drop happens quietly, without a decision to slow down.
• The fix is not more willpower. It is noticing the drift early and protecting two simple things: daily movement and resistance training, which together cut muscle loss dramatically.

The finding, in plain terms

When you take a GLP-1, you eat less, your weight comes down, and you feel lighter. So you would expect to move more. New data says the opposite happens.

Researchers presenting at ENDO 2026, the Endocrine Society's annual meeting, tracked the activity of people on these medications. As they lost weight, their average daily step count fell from about 5,047 to 4,487, and time spent in moderate-to-vigorous activity dropped from 28 minutes a day to 22. Nobody decided to become less active. It simply happened.

It is not hard to see why. These drugs lower appetite by acting on the same systems that govern energy and drive. Less fuel coming in, a body in a calorie deficit, a little less get-up-and-go, and the steps quietly disappear. The scale keeps dropping, so nothing feels wrong.

Why a quiet drop in movement is the muscle problem

Here is the part that makes this more than a curiosity. Across the GLP-1 class, when no deliberate steps are taken, roughly a quarter to a third of the weight lost is lean mass, muscle, not fat. Movement, and especially loading your muscles, is one of the main signals that tells your body to keep that muscle while you lose.

So a silent decline in activity is not a minor footnote. It is a direct line to losing the wrong kind of weight. You can be doing everything the drug asks of you, watching the scale reward you, and quietly arriving at your goal weight weaker than you started.

For women this is sharper. You begin with less muscle than men, and from your early forties, falling oestrogen speeds up the natural loss of it. A GLP-1's calorie deficit on top of a falling step count is a triple subtraction. (See GLP-1s in perimenopause.)

Why it is so easy to miss

The cruel part is that this decline is invisible from the inside. You are not lying on the sofa. You are living your normal life, just with slightly less spontaneous movement woven through it: one fewer walk, the lift instead of the stairs, a shorter loop with the dog. None of it registers as a choice. And the scale, the one number most people watch, actively reassures you, because it is still going down.

This is the general truth about GLP-1s that keeps coming up: the scale is the least informative number you can track. It cannot tell movement from muscle from fat. It just goes down and lets you assume the rest is fine.

What to do about it, without overhauling your life

The answer is not to force yourself into punishing exercise on a body that already has less fuel. It is smaller and more sustainable than that.

1. Make movement visible. You cannot protect what you do not measure. Simply knowing your step count turns an invisible drift into something you can respond to. A gentle floor, not a punishing target, is enough: aim to hold roughly where you were before the drug, not to set records.

2. Protect muscle directly with resistance training. Two short sessions a week is the minimum effective dose. Bodyweight squats, push-ups against a counter, a few rows, a hinge. Twenty minutes. The point is to give your muscles a reason to stay, not to exhaust yourself.

3. Eat enough protein to back it up. Movement without protein is a half-built defence. A floor of about 1.2 to 1.6 grams per kilogram of goal body weight, roughly 120g a day for most women, gives the muscle the raw material to hold on. (See why 120g of protein matters.)

Together, in the research, protein and resistance training cut lean-mass loss by 50 to 95% compared with losing weight without them. That is not a marginal effect. It is the difference between smaller-but-strong and smaller-but-frail.

What Steady does with this

This study describes the exact gap Steady was built to close. The danger is not a dramatic event you would notice. It is a slow, quiet drift in movement that the scale hides from you.

• Steady tracks your strength sessions alongside your nutrition, in a weekly scorecard, so "two sessions a week" stops being a good intention and becomes a number you can see.
• It sets a protein target to your goal weight, on the home screen, so the muscle has what it needs.
• It reads your weight trend as a shape, not a single daily number, so you stop trusting the one measurement that cannot tell muscle from fat.

The scale is the number every other app celebrates. Steady is built around the number that decides how you actually feel at the end: what you kept.

Read next: why muscle is the number that matters, protein on a GLP-1, and strength training that fits a tired body.

Sources

1. Endocrine Society. Physical activity declines in adults losing weight on GLP-1 receptor agonists, presented at ENDO 2026. ScienceDaily summary
2. Cermak NM, et al. Protein supplementation augments the adaptive response of skeletal muscle to resistance-type exercise: a meta-analysis. AJCN 2012. PubMed
3. Jäger R, et al. ISSN Position Stand: Protein and Exercise. JISSN 2017;14:20. PubMed
4. Volpi E, et al. Muscle tissue changes with aging (sarcopenia). Curr Opin Clin Nutr Metab Care 2004. PubMed

Medical disclaimer: Articles in the Steady research hub are educational, not medical advice. Talk to your prescriber before changing your activity, diet, or medication. See our full medical disclaimer.